19-5909053-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001017921.4(VMAC):​c.421G>A​(p.Gly141Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000262 in 1,563,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

VMAC
NM_001017921.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.39
Variant links:
Genes affected
VMAC (HGNC:33803): (vimentin type intermediate filament associated coiled-coil protein) Predicted to be located in cytoplasm. Predicted to be active in type III intermediate filament. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.031712532).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VMACNM_001017921.4 linkc.421G>A p.Gly141Ser missense_variant Exon 2 of 2 ENST00000339485.4 NP_001017921.1 Q2NL98

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VMACENST00000339485.4 linkc.421G>A p.Gly141Ser missense_variant Exon 2 of 2 1 NM_001017921.4 ENSP00000343348.2 Q2NL98
ENSG00000267314ENST00000588891.1 linkn.191+3972G>A intron_variant Intron 1 of 3 4 ENSP00000468419.1 K7ERU9

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
152090
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000119
AC:
2
AN:
167572
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000382
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000143
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000248
AC:
35
AN:
1411116
Hom.:
0
Cov.:
31
AF XY:
0.0000243
AC XY:
17
AN XY:
698688
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32294
American (AMR)
AF:
0.0000267
AC:
1
AN:
37440
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25334
East Asian (EAS)
AF:
0.0000271
AC:
1
AN:
36868
South Asian (SAS)
AF:
0.0000367
AC:
3
AN:
81834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43946
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
0.0000275
AC:
30
AN:
1089080
Other (OTH)
AF:
0.00
AC:
0
AN:
58610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152208
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41542
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68002
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.00000852
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 30, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.421G>A (p.G141S) alteration is located in exon 2 (coding exon 2) of the VMAC gene. This alteration results from a G to A substitution at nucleotide position 421, causing the glycine (G) at amino acid position 141 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
12
DANN
Benign
0.78
DEOGEN2
Benign
0.0039
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.51
T
M_CAP
Benign
0.0034
T
MetaRNN
Benign
0.032
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L
PhyloP100
2.4
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.021
Sift
Benign
0.55
T
Sift4G
Benign
0.57
T
Polyphen
0.057
B
Vest4
0.16
MutPred
0.17
Gain of glycosylation at G141 (P = 0);
MVP
0.040
MPC
0.48
ClinPred
0.039
T
GERP RS
2.4
Varity_R
0.040
gMVP
0.28
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs534520548; hg19: chr19-5909064; API